Genetic Transformation of Some Cherry Tomato (Lycopersicon esculentum Mill.) Cultivars with The HbsAg Gene

Date Received: 27-07-2014

Date Accepted: 24-09-2014

Date Published: 06-08-2025

Views

16

Downloads

18

Section:

KỸ THUẬT VÀ CÔNG NGHỆ

How to Cite:

Nam, N., Ha, T., Hao, L., Duc, L., Tri, P., Loc, P., … Ho, N. (2025). Genetic Transformation of Some Cherry Tomato (Lycopersicon esculentum Mill.) Cultivars with The HbsAg Gene . Vietnam Journal of Agricultural Sciences, 12(7), 1005–1014. https://doi.org/10.31817/tckhnnvn.2014.12.7.

Genetic Transformation of Some Cherry Tomato (Lycopersicon esculentum Mill.) Cultivars with The HbsAg Gene

Nguyen Thi Phuong Nam , Tran Thi Ngoc Ha , Le Hoan Hao , Le Tan Duc , Pham Duc Tri , Phan Tuong Loc , Nguyen Huu Tam , Bui Minh Tri , Nguyen Huu Ho (*)

  • Tác giả liên hệ: [email protected]
  • Keywords

    Agrobacterium tumefaciens, cherry tomato (Lycopersicon esculentum Mill.), cotyledon, genetic transformation, HBsAg gene

    Abstract


    The present paper reported the results on the genetic transformation of two cherry tomato cultivars, TN412 (pureline) and TN TN48 (F1 hybrid) with the HBsAg for long-term objective of producing the plant edible vaccine against Hepatitis B virus.  Shoots regenerated from cotyledons served as materials for transformation experiments. The 7-day old cotyledons of tomato seedlings were infected and co-cultivated for 2 days with the Agrobacterium tumefaciens strain carrying the HBsAg gene [driven by the PDS (phytoene desaturase) and T7 promoters], kanamycin resistance gene nptII and gusA reporter gene. Two days after co-cultivation, the cotyledons were washed with  cefotaxime solution and cultured on the MS medium containing + 0.5 mg/l IAA + 2 mg/l BA + 500 mg/l cefotaxime and 30 - 50 mg/l kanamycin for selection of transformants. Through at least 04 rounds of selection (15 - 20 days/round), various kanamycin resistant (KR) lines were obtained in both cultivars and they were confirmed for the presence and expression of transgenes by the GUS assay, by the PCR and Southern blot and western blot analyses. Several T1 individuals from T0 line were evaluated for presence and expression of the nptII gene by the in vitro KR assay and by the PCR analysis. The presence of the HBsAg gene in the T1 individuals also was carried out by the PCR technique.  

    References

    Arntzen CJ, Lam DMK (2000). Vaccines expressed in plants. US patent # 6,136,320.

    Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K (1987). Current Protocols in Molecular Biology, New York (USA), Green Publishing.

    Datta SK, Torrizo LB, Tu J, Oliva NP, Datta K (1997). Production and Molecular Evaluation of Transgenic Rice Plants. IRRI Discussion Paper Series, (21).

    Dellaporta SL, Wood J, Hicks JB (1983). A plant DNA minipreparation: Version II. Plant Mol.. Biol. Rep. 1(4): 19-21.

    Gamborg OL, Miller RA, Ojima K (1968). Nutrient requirement of suspensions cultures of soybean root cells. Exp. Cell Res. 50(1): 151-158.

    Gao Y, Ma Y, Li M, Cheng T, Li SW, Zhang J, Xia NS (2003). Oral immunization of animals with transgenic cherry tomatillo expressing HBsAg. World journal of Gastroenterology 9(5): 996-1002.

    Guo B, Chen Q, Guan ZJ, Tao GR, Xu LL, Hao HY, Wei YH (2012). Expression of HbsAg in tomatoes resulted in abnormal shoot regeneration in vitro. Pak. J. Bot. 44(4): 1413-1418.

    Huu Tam Nguyen, Leelavathi S, Reddy VS (2004). Bacteriophage T7 RNA polymerase-directed, inducible and tissue-specific over-expression of foreign genes in transgenic plants. Plant Biotechnology Journal 2: 301-310.

    Jefferson RA, Kavanagh TA, Bevan BW (1987). GUS fusion: -glucuronidase as a sensitive and versatile gene fusion marker in higher plants. EMBO 6: 3901-3907.

    Joung YH Youm JW, Jeon JH, Lee BC, Ryu, Hong HJ, Kim HC, Joung H, Kim HS (2004). Expression of the hepatitis B surface S and preS2 antigens in tubers of Solanum tuberosum. Plant Cell Rep, 22: 925-930.

    Kapusta J, Modelska A, Figlerowicz M, Podkowinski J, Pniewski T, Lisowa O, Berbezy P, Helias D, Biesiadka J, Femiak I, Letellier M, Yusibov V, Plucienniczak A, Koprowski H, Legocki AB (1999). Biotechnological approaches to making vaccine in plants. Plant Biotechnology and In vitro Biology in the 21st Century, A. Altman et al. (eds.), Kluwer Academic Publishers, pp. 571-574.

    Mason HS, Lam DMK, Arntzen CJ (1992). Expression of hepatitis B surface antigen in transgenic plants. Proc. Natl. Acad. Sci. USA, 89: 11745-11749.

    May GD, Afza R, Mason HS, Wiecko A, Novak FJ, Arntzen CJ (1995). Generation of transgenic banana (Musa acuminata) plants via Agrobacterium-mediated transformation. Biotechnology, 13: 486-492.

    Murashige T, Skoog F (1962). A revised medium for rapid growth and bioassays with tobacco tissue cultures. Physiol. Plant, 15: 473-497.

    Richter LJ, Thanavala Y, Arntzen CJ, Mason HS (2000). Production of hepatitis B surface antigen in transgenic plants for oral immunization. Nature Biotechnology, 18: 1167-1171.

    Sunil Kumar GB, Ganapathi TR, Revathi CJ, Prasad KSN, Bapat VA (2003). Expression of hepatitis B surface antigen in tobacco cell suspension cultures. Prot. Exp. Purif, 32: 10-17.

    Sunil Kumar GB, Ganapathi TR, Revathi CJ, Srinivas L, Bapat VA (2005). Expression of hepatitis B surface antigen in transgenic banana plants. Planta, 222: 484-493.

    Thanavala Y, Yang YF, Lyons P, Mason HS, Arntzen CJ (1995). Immunogenicity of transgenic plant-derived hepatitis B surface antigen. Proc. Natl. Acad. Sci. USA, 92: 3358-3361.